AI
DVAX

Axiom Investors’s Dynavax Technologies DVAX Stock Holding History

Axiom Investors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-67,015
Closed -$831K – 134
2018
Q3 		$831K Sell
67,015
-5,445
-8% -$73.7K 0.02% 131
2018
Q2 		$1.1M Buy
72,460
+5,460
+8% +$94.4K 0.03% 138
2018
Q1 		$1.33M Buy
+67,000
New +$1.16M 0.03% 138

Other funds holding DVAX

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Axiom Investors's DVAX Position: Q4 2018 in Review

Axiom Investors sold out of Dynavax Technologies (DVAX) in Q4 2018, closing a stake of 67,015 shares — an estimated $831K sold.

Axiom Investors first reported a position in DVAX in Q1 2018 and held it in 3 quarters. The position peaked at $1.33M in Q1 2018. 132 funds tracked by Wall St. Rank hold DVAX as of Q4 2018.

  • Axiom Investors reported no remaining Dynavax Technologies position as of Q4 2018 after selling out during the quarter.
  • Axiom Investors sold 67,015 Dynavax Technologies shares in Q4 2018, an estimated $831K.
  • Axiom Investors first reported a position in Dynavax Technologies in Q1 2018 and held it in 3 quarters.
  • Axiom Investors's Dynavax Technologies position peaked at $1.33M in Q1 2018.
  • 132 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2018.

Based on Axiom Investors's 13F filing for Q4 2018, filed 14 Feb 2019.